Answers are grounded in this paper and cite their sources.
Characterizes neurologic toxicity outcomes in CAR-T therapy, highlighting potential complications.
To characterize the clinical features and outcomes of non- Immune effector cell–associated neurotoxicity syndromes (NINTs) following Chimeric Antigen Receptor T-cell (CAR-T) therapy.
No takes yet. Share an insight, caveat, or question.
Afzal et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: